Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › FDA Clears Diazyme Sepsis Dx

FDA Clears Diazyme Sepsis Dx

Apr 25, 2017
|
staff reporter

NEW YORK (360Dx) – Diazyme Laboratories today said that the US Food and Drug Administration has provided 510(k) clearance to the company to market its procalcitonin assay for diagnosing sepsis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

  2. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

  3. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  4. FDA Approves Avioq's Supplemental HIV Test

  5. Scopio Labs Receives FDA 510(k) Clearance for Automated Hematology Platform

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.